Rapid point-of-care COVID-19 test shows promise in clinical study
September 18, 2020 -- A rapid COVID-19 test that can produce results at the point of care in just 90 minutes without sending samples to a central lab has demonstrated 94% sensitivity and 100% specificity, according to a new study published in the Lancet Microbe.  Discuss
How willing are U.S. adults to accept a COVID-19 vaccine?
September 17, 2020 -- A recent online survey of adults residing in the U.S. found that close to 70% of those surveyed would accept a COVID-19 vaccine if one were widely available. The study findings were published in the journal Vaccine on August 20.  Discuss
Experts draw lessons from FDA's hydroxychloroquine EUA controversy
September 8, 2020 -- Public health and regulatory experts advocated for changes to the U.S. Food and Drug Administration (FDA) emergency use authorization (EUA) process in a viewpoint published online August 31 in the Journal of the American Medical Association. They offer a set of recommendations to improve the process going forward as more COVID-19 vaccines and treatments emerge.  Discuss
Detecting SARS-CoV-2 in blood may be early indicator of severe disease
September 2, 2020 -- A blood test that measures SARS-CoV-2 RNA when patients are admitted to the hospital with COVID-19 symptoms can be a powerful diagnostic tool to predict how severe their disease will be, according to a study published in Clinical Infectious Diseases on August 28. Patients without viral RNA in their blood have a good chance at rapid recovery, concluded researchers from Karolinska Institutet and Danderyd Hospital.  Discuss
Top 5 facts about the IVD market
September 1, 2020 -- The market for IVD tests is vital and rapidly changing. IVD tests serve as a gateway to numerous other healthcare segments, and attract significant research and development spending and venture capital investments. Bruce Carlson of Kalorama Information explains the five facts that make the IVD market unique.  Discuss
FDA authorizes Abbott's COVID-19 real-time antigen test
August 27, 2020 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for a COVID-19 antigen test developed by Abbott Diagnostics Scarborough from which results can be read directly from the testing card.
NIH establishes Centers for Research in Emerging Infectious Diseases
August 27, 2020 -- The National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health (NIH), has awarded 11 grants for a first-year total value of approximately $17 million to establish the Centers for Research in Emerging Infectious Diseases.  Discuss
Data-sharing platform could help planning for future pandemics
August 24, 2020 -- In response to the global pandemic, the authors of a new paper are calling for a robust centralized platform to improve international data sharing among scientists and policymakers. The article was published on August 19 in the journal Science & Diplomacy.  Discuss
AI-based test diagnoses dental infection-related brain abscess
August 21, 2020 -- A pathogen detection test based on artificial intelligence (AI) was used to diagnose a patient's rare progressive brain abscess caused by a dental infection. Details were published on July 26 in a case report in the World Journal of Clinical Cases.  Discuss
HHS: FDA review not needed for coronavirus LDTs
August 20, 2020 -- Laboratory-developed tests (LDTs) to diagnose whether patients are infected with the SARS-CoV-2 virus will not have to undergo review by the U.S. Food and Drug Administration (FDA), according to an August 19 guidance by the U.S. Department of Health and Human Services (HHS).  Discuss